KALY - Kali, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0061
+0.0001 (+1.67%)
At close: 3:50PM EST
Stock chart is not supported by your current browser
Previous Close0.0060
Open0.0070
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0056 - 0.0070
52 Week Range0.0027 - 0.0393
Volume2,460,830
Avg. Volume9,494,353
Market Cap724,063
Beta (3Y Monthly)-29.41
PE Ratio (TTM)0.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    KALY – Kali-Extracts Confirms Second Bid On Its Cannabis Biopharmaceutical Technology Valued At $50 Million

    DALLAS, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed a second party has approached the company to express interest in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology valued at $50 million. KALY recently announced entering into discussions with a first investor to explore a possible sale of KALY’s cannabis biopharmaceutical technology. KALY management considers the valuation consistent with Goldman Small Cap Research’s recent valuation, but management maintains a position that the valuation still does not reflect the full potential of its intellectual property.

  • GlobeNewswire

    KALY – Kali-Extracts Announces Second Bidder On Its Cannabis Biopharmaceutical Technology Valued At $50 Million

    DALLAS, Nov. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a second party has approached the company to express interest in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million. KALY recently announced entering into discussions with a first investor to explore a possible sale of KALY’s cannabis biopharmaceutical technology. KALY management considers the valuation consistent with Goldman Small Cap Research’s recent valuation, but management maintains a position that the valuation still does not reflect the full potential of its intellectual property.

  • GlobeNewswire

    KALY – Kali-Extracts Encounters Second Wave Of CBD Extraction Contract Opportunities

    DALLAS, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced that the company’s CBD extraction offering is beginning to see a second wave of contract opportunities. KALY has so far announced three CBD extraction agreements with hemp farming operations worth a potential $15 million. Under the agreements, KALY consigns the crop and harvests the hemp in addition to executing the comprehensive CBD extraction process.

  • GlobeNewswire

    KALY – Kali Extracts Previews USDA Organic CBD Products

    DALLAS, Nov. 05, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to introduce USDA Organic CBD.

  • GlobeNewswire

    KALY – Kali-Extracts Confirms $50 Million Valuation Of Its Cannabis Biopharmaceutical Technology

    DALLAS, Nov. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million. Yesterday KALY announced taking a next step with the investor to explore a possible sale. KALY management has asked the investor to provide a “working” term-sheet for discussion purposes.

  • GlobeNewswire

    KALY – Kali-Extracts Explores $50 Million Cannabis Biopharmaceutical Technology Sale

    DALLAS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced taking a next step with the investor that has recently valued KALY’s biopharmaceutical technology at $50 Million. The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments. KALY management has asked the investor to provide a “working” term-sheet for discussion purposes.

  • GlobeNewswire

    KALY - Kali-Extracts Announces Third CBD Extraction Agreement Adding To $15 Million In Current Contracts

    DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a new CBD extraction agreement adding to the company’s previously announced extraction contracts with hemp farming operations worth a potential total of $15 million. This is a third consignment agreement whereby the hemp farming operation consigns its crop to KALY for harvesting and extraction and KALY, after processing the harvested hemp, markets the end product. KALY has been approached by multiple hemp farming operations, but so far has not signed any agreements to extract on a service agreement alone.

  • KALY – Kali Extracts Announces USDA Organic Certification For First Hemp Crop
    GlobeNewswire

    KALY – Kali Extracts Announces USDA Organic Certification For First Hemp Crop

    DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a USDA Organic Certification for its first crop hemp crop. KALY has a U.S. Patent for Cannabis Extraction and provides hemp cultivators with harvesting and extraction services. KALY has signed harvesting and extraction contracts so far worth approximately $15 million.

  • GlobeNewswire

    KALY – Kali-Extracts Entertains $50 Million Cannabis Biopharmaceutical Technology Acquisition Valuation

    DALLAS, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a $50 Million valuation for its cannabis extract biopharmaceutical technology. The valuation has been presented to KALY by an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments. KALY management has entered discussions with the investor but not formally expressed at this point that its willing to consider a sale.

  • GlobeNewswire

    KALY – Kali-Extracts To Review Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology This Wednesday, October 30, 2019

    DALLAS, Oct. 28, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to issue an update this.

  • GlobeNewswire

    PURA – Puration To Present THC Beverage Rollout Thursday This Week October 31st

    DALLAS, Oct. 28, 2019 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced the company will roll out plans for its THC Savor beverage in Canada this Thursday,.

  • GlobeNewswire

    PURA – Puration Announces THC Beverage Launch Plans

    DALLAS, Oct. 25, 2019 -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) today announced THC beverage launch plans.  With Canada legalizing cannabis infused beverages this.

  • GlobeNewswire

    KALY – Kali Extracts CEO Explores Hemp Expansion Industry In North Carolina

    DALLAS, Oct. 25, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri met with.

  • GlobeNewswire

    KALY – Kali-Extracts Confirms Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology

    DALLAS, Oct. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed a recent conditional acquisition proposal from an investor interested in the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented yesterday on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s technology is undervalued.  KALY plans to issue an update next Wednesday, October 30th, 2019 regarding the acquisition interest.

  • KALY – Kali-Extracts Announces New CBD Hemp4mula Gummies Now Available On USMJ.com
    GlobeNewswire

    KALY – Kali-Extracts Announces New CBD Hemp4mula Gummies Now Available On USMJ.com

    DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced its new CBD Hemp4mula Gummies are now available to order on www.usmj.com.

  • GlobeNewswire

    KALY – Kali-Extracts Announces Getting Courted For Potential Sale Of Cannabis Extract Biopharmaceutical Technology

    DALLAS, Oct. 23, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced the company has recently received serious interest from an investor exploring the acquisition of KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s technology is undervalued.

  • KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest
    GlobeNewswire

    KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest

    DALLAS, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today published photos on the company’s website from its first historic hemp harvest since the Federal legalization of hemp cultivation in the United States.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  KALY has hired a photo journalist to record the event. The State of New York alone, where KALY is already working, has a reported 18,000 acers of hemp in just the Hudson Valley area. KALY is planning on concentrating its CBD extraction services in just the North East this fall and expanding nationwide next year.

  • GlobeNewswire

    USMJ Reports 23% Revenue Growth To Over $1 Million With Nearly 10% Net Profit

    DALLAS, Oct. 15, 2019 -- via OTC PR WIRE – North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today announced reporting $1,059,471 in revenue for its fiscal year end.

  • GlobeNewswire

    KALY – Kali-Extracts Reports Increased Interest In Patented Cannabis Extraction Process In Reaction To Cannabis 2.0

    DALLAS, Oct. 15, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced recent interest from Canadian.

  • GlobeNewswire

    KALY – Kali-Extracts Hemp Harvest And CBD Extraction In Full Swing

    DALLAS, Oct. 14, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced engaging a photo journalist to record the company’s first historic hemp harvest since the Federal legalization of hemp cultivation in the United States.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  The first photos taken by the photo journalist are expected to be published later this week. The State of New York alone, where KALY is already working, has a reported 18,000 acres of hemp in just the Hudson Valley area. KALY is planning on concentrating its CBD extraction services in just the North East this fall and expanding nationwide next year.

  • GlobeNewswire

    KALY – Kali-Extracts Is Making CBD Infused Coffee

    DALLAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced today announced that as part of the sole license it has granted to Puration, Inc. (PURA) for use of the KALY U.S. Patented Cannabis Extraction Process for the production of beverages, KALY has recently been engaged by PURA to design a coffee infusion process.

  • GlobeNewswire

    PURA – Puration Announces CBD Infused Fair Trade Coffee From Kenya

    PURA currently makes and sells EVERx CBD Sports Water, the leading CBD sports drink in the sports nutrition market.  PURA has reported over $1 million in CBD beverage sales in the first six months of 2019 after reporting approximately $1 million in sales for all of 2018.  On top of its ongoing sales, PURA has signed a new European distribution agreement anticipated to generate $4 million annually with a first shipment scheduled later this month. A few months ago, PURA launched an initiative to partner with other beverage companies and introduce CBD Infused beer, coffee and tea beverages.  As part of the initiative, PURA engaged Goldman Small Cap Research to conduct a CBD beverage industry survey (see link below).  Yesterday, Goldman published the final survey results of the survey.

  • GlobeNewswire

    KALY – Kali-Extracts Announces Exploding Demand For Its CBD Extraction Services

    DALLAS, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced what it referred to as “exploding” demand for its CBD extraction services.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  Word is out on KALY’s process and KALY is receiving what it characterizes as “non-stop” calls for extraction services.  “The hemp harvesting season has hit and I think some of the first-time hemp farmers are realizing now that they don’t’ have the equipment to extract CBD from hemp,” said Frederick Ferri, CEO of KALY. “The equipment is expensive and even if you’ve got the funds, good luck finding the equipment now.”  The State of New York alone, where KALY is already working, has a reported 18,000 acers of hemp in just the Hudson Valley area.

  • GlobeNewswire

    PURA – Puration Prospects Rise With Cannabis Legalization 2.0

    DALLAS, Oct. 09, 2019 -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) today revealed the recent increase in inquiries it is receiving from cannabis businesses in Canada.

  • GlobeNewswire

    KALY – Kali-Extracts Developing OTC and Prescription CBD Treatments

    DALLAS, Oct. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed the company is pursuing the development of Over-The-Counter (OTC) and prescription CBD treatments.  The company yesterday released an update on its latest Cannabis Extract Biopharmaceutical developments.  The information from yesterday’s release to include the specifics on the OTC and prescription CBD treatments is contained here in today’s release.